on AMOEBA (EPA:ALMIB)
Amoéba is entering a new commercial phase with Koppert
Amoéba, a French company specializing in microbiological solutions, has received its first order from Koppert, a leader in biocontrol. This event marks Amoéba's transformation into a commercial company. The order, part of a distribution agreement signed in June 2025, covers vineyards and vegetable crops in 18 European countries as well as the United States.
Deliveries will begin in April 2026. The partnership with Koppert envisions a phased approach, targeting priority areas before expanding the product range. The promising collaboration is exemplified by the successful launch of TIAGAN, designed for the vineyard market.
Amoéba structures its activities around its subsidiary Green 4 Agro, headed by Jean-Marc PETAT. This will allow it to respond to the growing demand for environmentally friendly solutions to fungal diseases.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all AMOEBA news